Physician profile
Charles Mango
NPI 1528025129
$4,200.45
in general payments reported to CMS, 2019-2025
19 companies · $718 in 2025
The $718 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,160 · 2020: $91.59 · 2021: $151 · 2022: $838 · 2023: $411 · 2024: $832 · 2025: $718.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,960.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,960.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,177.97 | 2019-2025 | Eylea Hd, Eylea |
| Abbvie INC. | $625.12 | 2022-2025 | |
| Genentech USA, INC. | $518.81 | 2019-2024 | Vabysmo |
| Astellas Pharma US INC | $416.13 | 2023-2025 | Izervay |
| Dutch Ophthalmic, USA | $401.93 | 2019-2023 | Tissueblue, Eva, Combined Machine |
| Eyepoint US, INC. | $270.88 | 2022 | |
| Allergan, INC. | $188.23 | 2019 | |
| Carl Zeiss Meditec, INC. | $127.31 | 2019 | |
| Novartis Pharmaceuticals Corporation | $98.42 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $72.92 | 2021-2024 | Acthar |
| Biogen, INC. | $62.52 | 2023-2024 | Byooviz |
| Harrow Eye, LLC | $55.22 | 2025 | Iheezo, Triesence |
| Ani Pharmaceuticals, INC. | $54.90 | 2025 | Yutiq, Iluvien |
| Apellis Pharmaceuticals, INC. | $33.46 | 2025 | Syfovre |
| Coherus Oncology, INC. | $25.19 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $19.61 | 2023 | Iluvien |
| Aerie Pharmaceuticals, INC. | $18.18 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $17.21 | 2021 | |
| Mallinckrodt Enterprises LLC | $16.44 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Mango listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.